EnteroBiotix
EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.
7
Funding Rounds
$90.2m
Money raised
Overview
EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.
-
Website:
- Headquarters: Edinburgh
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company EnteroBiotix has raised a total of $90.22m in funding over 7 rounds.
Key Insights:
- EnteroBiotix April 2024 Series B Funding Round: $29m
- EnteroBiotix LTD Funding Round, September 2022: $12.99m
- EnteroBiotix Series A round, September 7, 2022: $21.5m
- EnteroBiotix September 2021 Series A Funding Round: $21m
- EnteroBiotix Seed round, May 2019: $2.6m
- EnteroBiotix May 2019 Seed Funding Round: $2.5m
- EnteroBiotix June 2017 Seed Funding Round: $630k
EnteroBiotix April 2024 Series B Funding Round
$29m
EnteroBiotix LTD Funding Round, September 2022
$12.99m
EnteroBiotix Series A round, September 7, 2022
$21.5m
EnteroBiotix September 2021 Series A Funding Round
$21m
EnteroBiotix Seed round, May 2019
$2.6m
EnteroBiotix May 2019 Seed Funding Round
$2.5m
EnteroBiotix June 2017 Seed Funding Round
$630k
Industries
EnteroBiotix is active in the following industries: